Logo


Ticker
Arrow Up NYSE Composite   NYSE   11020.37    +139.77 (+1.3%) Arrow Up Alibaba Group Holding   BABA    111.41     -3.69 (-3.2%) Arrow Up Dean Foods   DF    17.16     +0.55 (+3.3%) Arrow Up Direxion Gold Miners Bull 3X   NUGT    15.79     +1.86 (+13.4%) Arrow Up Genworth Financial   GNW    9.56     +0.15 (+1.6%) Arrow Up Meritor, Inc.   MTOR    14.15     +0.05 (+0.4%) Arrow Up Mrk Vectr Gold Miners E.T.F.   GDX    19.99     +0.97 (+5.1%) Arrow Up Mrk Vectr Jr Gold Miner E.T.F.   GDXJ    29.43     +3.08 (+11.7%) Arrow Up Santander Consumer USA Holding   SC    18.33     -1.19 (-6.1%) Arrow Up SPDR S&P 500 E.T.F.   SPY    206.58     +2.34 (+1.2%) Arrow Up NASDAQ Composite   NASDAQ   4688.54    +56.01 (+1.2%) Arrow Up Achillion Pharmaceuticals   ACHN     13.16    -0.81 (-5.8%) Arrow Up Apple   AAPL     116.46    +2.28 (+2.0%) Arrow Up BlackBerry Limited   BBRY     10.24    -0.96 (-8.6%) Arrow Up Cisco Systems   CSCO     26.81    +0.49 (+1.9%) Arrow Up Comcast Corp.   CMCSA     54.04    -0.06 (-0.1%) Arrow Up Orexigen Therapeutics   OREX     5.86    +0.21 (+3.7%) Arrow Up Susquehanna Bancshares   SUSQ     13.10    -0.05 (-0.4%) Arrow Up NYSE AMEX Composite   AMEX   2617.96   +33.70 (+1.3%) Arrow Up Cheniere Energy Partners LP   CQH    22.23    -0.92 (-4.0%) Arrow Up Energy Fuels   UUUU    7.70    -0.09 (-1.2%) Arrow Up New Gold   NGD    4.32    +0.24 (+5.9%) Arrow Up S&P/TSX Composite   TSX   15116.32    +273.22 (+1.8%) Arrow Up Birchcliff Energy   BIR    11.74    +0.61 (+5.5%) Arrow Up BlackBerry Limited   BB    11.52    -1.12 (-8.9%) Arrow Up Bombardier Inc.   BBD.B    4.30    +0.24 (+5.9%) Arrow Up Exchange Income   EIF    22.81    +0.23 (+1.0%) Arrow Up Gear Energy   GXE    3.48    -0.06 (-1.7%) Arrow Up Noranda Income Fund   NIF.UN    2.15    -0.23 (-9.7%) Arrow Up Yamana Gold Inc.   YRI    4.61    +0.24 (+5.5%)

    

  (format: symbol-exchange code e.g. IBM-N)

Exchange Codes:  T-Toronto N-New York A-American Q-Nasdaq I-Index
close window
  • Stock Trends Report
  • Charting
  • Industry
  • Profile
NASDAQ BCRX
week ending
Friday Nov 14, 2014
   
Biocryst Pharmaceuticals
Trend Trend Counters Relative Strength  
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding.
Trend / Category
6/ 70
13 week Current wk Unusual Volume
69 -
n/a
  weeks in vs. S&P500  
Trading stats for the Week ST Chart - click for more ST charts
  Close Range
$US 10.08 9.85 - 11.25
1 week %change 13 week %change
-3.6% -27.6%
Average Price
13 week MA 40 week MA
11.62 11.02
52-week range
5.31 - 14.62
Share Volume Transactions
3,315,600 23,386
Avg traded value Relative Volume
$1,429 5.5%
Total traded value
$33,421,248
Historical ST Data | ST Charts
Biocryst Pharmaceuticals (BCRX-Q)
Trend Rel
Str
+
-
52wk
Hi | Lo
Stock Name
Symbol
Wk Close
Wk
%Chg
Wk
Range
Vol (00's)
Trades
Biotechnology
72 - 6.36 | 1.84 22nd Century Group XXII 2.14 -7.4 2.10 - 2.38 5132 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1956
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 11/12 82 + 7.00 | 2.55 Aastrom Biosciences ASTM 2.86 +4.4 2.65 - 2.95 4815 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1565
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/9 115 - 32.00 | 15.64 ACADIA Pharmaceuticals ACAD 27.14 -2.0 26.57 - 28.48 67241 46994
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 16/55 51 - 1.80 | 0.45 Acasti Pharma ACST 0.49 -2.0 0.47 - 0.50 2866 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 278
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 7/22 108 + 57.89 | 19.15 Acceleron Pharma XLRN 33.50 +11.0 29.82 - 38.26 15286 13223
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/22 145 + 15.00 | 2.45 Achillion Pharmaceuticals ACHN 13.97 +38.2 10.67 - 15.00 848178 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 272719
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/18 101 - 39.95 | 27.51 Acorda Therapeutics Inc. ACOR 33.47 -4.7 33.11 - 36.48 22181 19576
87 - 15.00 | 5.90 Actinium Pharmaceuticals ATNM 5.92 -16.4 5.90 - 7.13 4948 2497
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/18 100 + 5.99 | 2.46 Advaxis ADXS 2.99 +8.7 2.72 - 3.06 6465 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1662
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 6/44 63 - 76.43 | 19.10 Aegerion Pharmaceuticals AEGR 19.66 -8.9 19.36 - 22.17 51528 33722
Bearish Crossover (aka 'Newly Bearish' Trend). The stock's Trend Category has changed from BULLISH to BEARISH. The 13-week MA, which was above the 40-week MA a week previous, has now moved below it. A stock exhibiting this Trends Symbol is in the 1st week of its new BEARISH Trend Category. Trading implications: generally considered a trade exit signal. 1/1 43 - 1.70 | 0.55 AEterna Zentaris AEZS 0.56 -1.8 0.56 - 0.65 100608 7808
0 + 7.00 | 3.55 Affimed N.V. AFMD 5.40 +8.0 4.33 - 5.49 739 502
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/8 87 - 5.27 | 2.27 Agenus Inc. AGEN 2.98 -1.3 2.93 - 3.16 17672 8780
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 14/30 195 + 89.50 | 15.77 Agios Pharmaceuticals AGIO 84.06 +16.7 73.16 - 89.50 40362 35283
45 + 31.00 | 8.60 Akebia Therapeutics AKBA 11.98 +12.0 8.60 - 12.63 18512 11008
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 2/36 77 - 23.95 | 9.71 Albany Molecular Research AMRI 16.13 -4.2 16.03 - 18.08 34485 23796
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/25 17 - 25.44 | 3.26 Alcobra Ltd. ADHD 3.66 -2.4 3.52 - 3.85 8543 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 2758
97 - 22.95 | 9.50 Alder BioPharmaceuticals, Inc. ALDR 15.80 -4.7 15.50 - 17.47 4461 3468
178 + 11.99 | 3.00 Aldeyra Therapeutics ALDX 7.47 +4.9 7.02 - 7.95 1085 805
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 27/74 106 - 197.64 | 117.33 Alexion Pharmaceuticals ALXN 188.76 -2.6 187.06 - 197.00 37421 43504
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/5 128 - 112.57 | 47.03 Alnylam Pharmaceuticals ALNY 90.12 -6.0 89.88 - 102.76 30066 28164
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/5 240 + 16.25 | 4.80 Ambit Biosciences Corp. AMBI 15.60 +1.7 15.40 - 16.25 1401 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 685
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 15/16 114 - 164.65 | 108.20 Amgen AMGN 157.68 -1.6 156.62 - 163.86 178481 136433
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 3/20 123 - 7.63 | 1.77 Amicus Therapeutics FOLD 5.69 -0.5 5.61 - 6.50 44735 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 24106
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 11/12 146 + 32.45 | 12.38 Anacor Pharmaceuticals, Inc. ANAC 31.00 +8.4 28.36 - 32.45 21236 18484
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 178 + 54.24 | 11.80 ANI Pharmaceuticals ANIP 53.95 +17.3 46.11 - 54.24 20076 15498
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 5/6 93 - 52.49 | 28.79 Anika Therapeutics ANIK 39.57 -1.2 39.46 - 42.24 9277 9872
113 - 34.37 | 11.10 Applied Genetic Technologies AGTC 23.05 -12.0 22.61 - 28.24 2418 1719
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/28 106 + 25.50 | 9.20 Aratana Therapeutics PETX 12.19 +9.2 11.01 - 13.38 12720 9842
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 19/23 63 - 2.54 | 0.84 ARCA biopharma ABIO 0.89 -12.8 0.84 - 1.06 10124 1935
178 - 25.23 | 11.37 Ardelyx, Inc. ARDX 21.64 -7.9 20.90 - 23.70 1225 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1135
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/17 100 + 7.97 | 3.26 Arena Pharmaceuticals ARNA 4.53 +6.3 4.22 - 4.91 233729 60678
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/17 100 + 9.83 | 2.50 ARIAD Pharmaceuticals ARIA 6.15 +1.2 6.04 - 6.62 230237 78307
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 42/69 86 + 2.92 | 1.04 Arqule Inc. ARQL 1.17 +10.4 1.10 - 1.25 35115 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 5062
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/48 88 - 6.07 | 2.98 Array BioPharma ARRY 3.56 -8.3 3.54 - 3.98 66344 27670
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/20 42 - 27.63 | 5.47 Arrowhead Research ARWR 6.04 -0.3 5.82 - 6.79 150225 66492
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/24 83 - 4.33 | 1.08 Athersys Inc. ATHX 1.37 -10.5 1.31 - 1.59 16266 5188
119 - 37.38 | 22.00 Avalanche Biotechnologies AAVL 33.96 -3.0 32.70 - 35.71 3834 3379
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/160 74 + 2.20 | 0.85 AVEO Pharmaceuticals AVEO 0.94 +5.6 0.86 - 1.05 9820 1818
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/22 106 + 15.77 | 7.61 BIND Therapeutics BIND 10.26 +11.3 9.00 - 10.38 7680 4104
67 - 11.00 | 5.00 Bio Blast Pharma Ltd. ORPN 5.10 -4.7 5.10 - 5.39 206 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 112
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/20 90 - 97.15 | 82.51 Bio-Techne Corp. TECH 90.64 -0.1 89.95 - 92.57 7059 8820
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 6/70 69 - 14.62 | 5.31 Biocryst Pharmaceuticals BCRX 10.08 -3.6 9.85 - 11.25 33156 23386
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 2/64 105 - 18.48 | 4.21 BioDelivery Sciences Intl. BDSI 14.47 -6.7 14.32 - 16.57 40021 27988
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/219 85 - 358.89 | 239.81 Biogen IDEC BIIB 305.43 -4.8 300.35 - 330.37 65083 74309
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 21/29 71 - 3.34 | 1.26 BioLineRx Ltd. BLRX 1.34 -6.3 1.30 - 1.40 3433 952
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/6 118 - 88.23 | 55.04 Biomarin Pharmaceuticals BMRN 82.85 -1.3 82.67 - 88.23 55734 48750
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 40/80 126 - 42.00 | 20.32 BioSpecifics Technologies (D) BSTC 38.97 -1.0 37.88 - 40.83 4598 4023
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 23/24 86 - 7.07 | 2.10 Biota Holdings Ltd. BOTA 2.25 -2.2 2.17 - 2.34 1521 596
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 110 + 4.18 | 2.21 Biotime Inc. BTX 3.43 +1.8 3.31 - 3.46 6302 2492
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/22 103 - 43.27 | 17.03 bluebird bio BLUE 39.14 -4.6 38.60 - 43.27 21344 16652
0 - 4.35 | 3.31 Brainstorm Cell Therapeutics BCLI 3.47 -4.4 3.33 - 3.75 6811 5357
0 - 11.70 | 6.51 Calithera Biosciences CALA 9.88 -0.5 9.75 - 10.74 2478 1678
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/3 103 + 24.14 | 15.20 Cambrex Corp. CBM 23.17 +2.3 22.65 - 24.14 11525 9518
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/13 60 - 9.46 | 2.29 Can-Fite BioPharma CANF 2.41 -7.0 2.29 - 2.75 461 169
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/3 79 - 23.25 | 7.53 Cara Therapeutics CARA 8.40 -3.0 7.83 - 8.90 5339 2994
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/18 80 - 2.34 | 1.50 CASI Pharmaceuticals, Inc. CASI 1.56 -4.3 1.50 - 1.69 759 320
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 9/10 57 + 1.90 | 0.53 Cel Sci Corp CVM 0.65 +8.3 0.59 - 0.66 16669 2033
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/19 111 - 109.25 | 66.85 Celgene Corp. CELG 104.05 -2.3 102.13 - 109.17 214349 174179
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/3 106 + 17.16 | 7.45 Celladon Corporation CLDN 11.63 +1.1 11.33 - 13.00 3739 2754
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/32 90 + 33.33 | 10.76 Celldex Therapeutics CLDX 14.16 +5.5 13.13 - 15.27 137325 68224
82 + 3.50 | 1.76 Cellectar Biosciences, Inc. CLRB 2.73 +2.6 2.38 - 3.01 1199 338
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 19/30 64 + 22.49 | 5.75 Cellular Dynamics Int'l ICEL 7.59 +0.8 7.30 - 7.85 1077 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 820
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 16/52 78 + 4.74 | 2.38 Celsion Corporation (D) CLSN 2.53 +0.4 2.40 - 2.63 2378 1158
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/3 96 - 9.20 | 4.63 Celsus Therapeutics CLTX 5.62 +0.4 5.60 - 6.00 44 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 21
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 138 - 15.39 | 8.10 Cempra, Inc. CEMP 13.60 -1.2 13.55 - 14.80 12916 8246
116 + 8.06 | 3.35 Cerulean Pharma Inc. CERU 6.08 +10.3 5.25 - 6.08 1412 766
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/31 113 + 8.00 | 3.48 Cerus Corp. CERS 4.41 +10.0 3.86 - 4.65 67819 27732
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/25 93 + 8.25 | 4.09 ChemoCentryx Inc. (D) CCXI 4.93 +4.9 4.62 - 5.23 3209 1882
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 24/35 124 + 36.75 | 13.29 Chimerix, Inc. CMRX 32.24 +4.9 30.36 - 34.70 28439 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 25210
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 39/118 140 - 69.97 | 26.66 China Biologic Products CBPO 66.60 -3.3 56.00 - 69.00 5329 4128
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/68 91 - 1.45 | 0.33 Cleveland BioLabs (D) CBLI 0.40 -9.1 0.37 - 0.45 14964 2132
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 7/24 119 - 93.33 | 35.33 Clovis Oncology CLVS 54.89 -5.9 54.55 - 61.48 35015 29565
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/14 93 - 3.30 | 1.24 Codexis, Inc. CDXS 2.30 -4.2 2.23 - 2.50 2996 1142
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 10/26 72 - 14.32 | 6.35 Compugen Ltd. CGEN 6.55 -8.1 6.35 - 7.20 8902 4652
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/28 99 + 15.67 | 5.06 Conatus Pharmaceuticals CNAT 7.24 +5.7 6.82 - 7.40 10803 5106
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/1 129 - 16.26 | 7.12 Concert Pharmaceuticals CNCE 13.04 -0.5 12.31 - 13.70 5522 3331
0 - 5.50 | 2.90 ContraFect Corp. CFRX 3.00 -9.1 2.92 - 3.28 219 68
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 15/20 105 - 4.49 | 1.69 Corcept Therapeutics CORT 3.02 +0.3 2.90 - 3.13 5679 3660
85 - 8.49 | 5.10 Corium International CORI 5.20 -9.6 5.10 - 5.70 340 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 189
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/18 73 - 3.20 | 0.66 CorMedix Inc. CRMD 1.52 -10.1 1.38 - 1.75 3437 756
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/61 100 + 3.31 | 1.26 Coronado Biosciences CNDO 1.82 +4.6 1.50 - 1.87 9365 1997
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 15/16 79 - 4.25 | 1.69 CTI BioPharma Corp. CTIC 2.13 -0.5 2.09 - 2.23 76446 23096
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/23 107 - 82.12 | 58.50 Cubist Pharmaceuticals CBST 70.52 +0.2 69.70 - 73.48 20311 21118
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 15/49 76 - 3.65 | 1.19 Curis Inc CRIS 1.30 nc 1.22 - 1.39 21125 7682
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/31 91 - 5.25 | 2.68 Cyclacel Pharmaceuticals CYCC 2.99 -3.2 2.93 - 3.23 3889 1306
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/26 90 + 13.26 | 3.05 Cytokinetics Inc. (D) CYTK 4.23 +3.2 4.03 - 4.60 14859 7243
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 24/25 25 - 3.47 | 0.36 Cytori Therapeutics (D) CYTX 0.43 nc 0.36 - 0.48 85583 12271
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 19/27 83 - 8.35 | 2.05 Cytrx Corp. CYTR 2.79 -2.8 2.72 - 2.91 22418 7407
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/30 59 - 4.40 | 0.77 DARA Biosciences DARA 0.80 -4.8 0.77 - 0.86 10127 1708
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 43/79 8 - 3.52 | 0.11 Dendreon Corp. DNDN 0.11 -88.3 0.11 - 0.34 1555181 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 117737
0 + 18.50 | 12.68 Dermira, Inc. DERM 16.05 +1.7 15.62 - 16.35 1538 1273
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/3 61 + 46.00 | 8.00 Dicerna Pharmaceuticals DRNA 9.27 +1.8 8.94 - 9.71 5168 3646
108 - 15.86 | 8.00 Dipexium Pharmaceuticals DPRX 10.28 -10.8 9.75 - 11.63 998 742
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/27 91 + 2.77 | 1.51 Discovery Laboratories DSCO 1.58 +2.6 1.51 - 1.64 10224 3383
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/63 150 - 24.33 | 9.94 Durata Therapeutics DRTX 23.75 -1.1 23.72 - 24.12 61220 14437
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 15/16 125    13.66 | 6.05 Dyax DYAX 12.83 +0.4 12.62 - 13.66 52668 37047
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/2 69 - 19.85 | 3.81 Egalet Corporation EGLT 6.33 -6.8 6.18 - 6.89 682 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 469
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/2 89 - 19.33 | 9.50 Eleven Biotherapeutics EBIO 11.00 -0.6 10.63 - 11.49 650 598
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/20 101 + 28.48 | 19.31 Emergent BioSolutions EBS 24.22 +1.1 23.61 - 25.00 9971 8842
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 14/48 107 + 48.49 | 20.50 Enanta Pharmaceuticals ENTA 44.24 +2.1 42.75 - 44.80 11442 10548
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/22 91 + 33.70 | 5.31 Endocyte, Inc. ECYT 6.42 +6.5 5.85 - 6.87 51187 24996
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 9/12 86 - 1.83 | 0.78 Enzon, Inc. ENZN 1.09 -1.8 1.06 - 1.15 5097 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1440
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 21/21 77 + 35.12 | 6.34 Enzymotec Ltd. ENZY 7.27 +6.3 6.35 - 7.50 1984 1006
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 19/50 45 - 22.50 | 3.84 EPIRUS Biopharmaceuticals EPRS 3.95 -12.4 3.84 - 4.60 1134 598
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 3/16 60 - 41.23 | 18.75 Epizyme, Inc. EPZM 22.97 -3.3 22.37 - 24.94 12687 12221
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 16/18 177 + 31.34 | 10.90 Esperion Therapeutics Inc ESPR 29.81 +18.4 24.93 - 31.34 12421 10178
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/13 73 - 20.39 | 9.82 Evogene Ltd. EVGN 9.96 -5.1 9.82 - 10.70 1266 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 710
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 26/45 126 + 26.79 | 10.46 EXACT Sciences EXAS 23.00 +0.8 22.18 - 23.63 48265 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 29951
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 11/30 39 - 8.41 | 1.35 Exelixis Inc EXEL 1.73 -0.6 1.70 - 1.88 113465 25929
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 20/20 69 - 13.55 | 3.90 Fate Therapeutics FATE 3.96 -2.2 3.90 - 4.29 1495 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 424
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/22 121 + 23.33 | 8.40 Five Prime Therapeutics FPRX 15.19 +5.8 13.99 - 15.50 4261 2618
0 + 11.00 | 4.75 Foamix Pharmaceuticals Ltd. FOMX 5.38 +0.8 5.25 - 5.54 1742 878
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 14/29 71 - 7.77 | 1.56 Galena Biopharma GALE 1.87 -4.1 1.84 - 1.98 36623 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 7612
74 - 18.73 | 5.33 Galmed Pharmaceuticals GLMD 5.90 -0.5 5.72 - 6.13 4564 3598
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/2 64 + 23.99 | 7.00 Genocea Biosciences GNCA 8.90 +2.5 8.65 - 9.05 1088 920
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 9/21 85 - 4.25 | 1.35 Genvec, Inc. GNVC 1.86 -4.1 1.80 - 2.02 1972 586
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/30 110 + 6.54 | 1.31 Geron Corp GERN 2.76 +18.5 2.21 - 3.33 408888 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 74496
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/150 98 - 116.83 | 63.50 Gilead Sciences GILD 102.06 -4.1 100.00 - 109.37 908556 552180
72 - 15.00 | 4.29 GlobeImmune, Inc. GBIM 6.30 -0.9 6.02 - 6.60 871 471
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 19/63 51 - 2.35 | 0.41 GTx Inc. (D) GTXI 0.55 -3.5 0.51 - 0.60 5321 853
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/29 83 - 18.18 | 6.88 Halozyme Therapeutics HALO 8.54 -6.4 8.30 - 9.32 74903 44606
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 2/4 106 - 9.59 | 3.60 Heat Biologics HTBX 4.44 -15.6 4.29 - 5.24 1654 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 805
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 4/18 96 - 0.55 | 0.19 Hemispherx Biopharma Inc HEB 0.27 -6.9 0.26 - 0.30 41797 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 4139
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/14 81 - 32.98 | 19.45 Hyperion Therapeutics HPTX 21.19 -2.9 21.09 - 22.22 8170 6368
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/9 240 - 3.48 | 0.24 iBio, Inc. IBIO 1.05 -9.5 1.05 - 1.41 120476 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 19155
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 20/23 89 + 6.87 | 1.81 Idera Pharmaceuticals (D) IDRA 2.45 +0.8 2.34 - 2.61 21898 7523
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 30/89 144 - 10.49 | 2.71 IGI Laboratories Inc. IG 9.18 -2.9 8.70 - 9.84 24684 13346
85 - 10.64 | 5.36 Ignyta, Inc. RXDX 6.63 -0.3 6.53 - 7.10 951 589
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/107 103 - 197.37 | 91.03 Illumina Inc. ILMN 180.50 -3.1 178.12 - 191.62 54978 55945
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/17 100 + 5.68 | 3.30 Immucell Corp ICCC 4.80 +4.6 4.66 - 5.00 125 70
272 + 36.69 | 11.51 Immune Design Corp. IMDZ 35.22 +17.2 28.52 - 36.69 2488 2245
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 24/48 69 + 4.00 | 0.53 ImmunoCellular Therapeutics IMUC 0.65 +3.2 0.56 - 0.67 35288 7291
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 21/53 79 - 17.80 | 7.70 Immunogen Inc. IMGN 9.53 -2.5 9.16 - 10.39 74892 43128
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/47 108 + 6.17 | 3.04 Immunomedics IMMU 3.76 +4.2 3.52 - 3.99 22903 11210
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 17/36 103 - 9.62 | 3.01 Imprimis Pharmaceuticals IMMY 8.60 -0.9 8.46 - 8.80 497 210
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 130 - 72.80 | 40.30 Incyte Corporation INCY 69.54 +0.3 68.27 - 72.80 62933 54986
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/2 96 - 5.60 | 5.60 Indevus Pharmaceuticals Inc IDEV 5.60 nc nt nt nt
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/8 119 + 18.35 | 8.40 Infinity Pharmaceuticals INFI 14.10 +8.4 12.68 - 14.76 39113 29434
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 113 - 15.80 | 7.44 Inovio Pharmaceuticals, Inc. INO 11.00 -2.1 10.67 - 11.46 36313 14938
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/26 96 - 22.29 | 11.25 Insmed, Inc. INSM 13.21 -6.5 13.17 - 14.62 26664 18738
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 106 + 57.91 | 20.52 Insys Therapeutics INSY 38.57 +6.6 36.06 - 41.86 33053 25318
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/28 104 + 38.50 | 13.13 Intrexon Corp. XON 23.46 +10.9 20.97 - 25.00 54702 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 34096
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/215 113 + 180.00 | 107.74 Jazz Pharmaceuticals JAZZ 174.57 +2.2 170.11 - 176.84 32897 34418
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/15 87 - 18.48 | 11.53 Keryx Biopharmaceuticals KERX 15.21 -9.1 15.12 - 16.73 61220 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 36052
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 10/10 56 - 26.99 | 8.13 Kindred Biosciences KIN 8.74 -2.9 8.62 - 9.16 5041 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 4239
167 - 48.19 | 21.00 Kite Pharma KITE 39.34 -14.5 37.76 - 46.74 26117 16623
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/3 108 - 19.50 | 6.17 La Jolla Pharmaceutical (D) LJPC 11.06 -9.9 11.00 - 13.97 15413 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 7632
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/47 77 - 2.45 | 1.04 Lexicon Pharmaceuticals LXRX 1.28 -5.2 1.28 - 1.48 33545 9752
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/15 98 + 80.42 | 41.99 Ligand Pharmaceuticals LGND 57.79 +7.1 53.18 - 58.48 15170 15761
84 - 16.45 | 10.00 Loxo Oncology, Inc. LOXO 11.45 -4.6 10.90 - 12.09 910 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 648
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 6/49 77 - 5.30 | 2.55 Lpath Inc. LPTN 2.68 -9.8 2.55 - 2.98 1628 509
87 - 10.20 | 6.82 Macrocure Ltd. MCUR 7.50 nc 7.22 - 7.72 426 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 301
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/19 109 + 41.00 | 17.31 MacroGenics, Inc. MGNX 23.27 +17.3 19.52 - 25.18 21851 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 13497
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 4/5 86 + 11.48 | 3.80 MannKind MNKD 6.16 +6.6 5.70 - 6.36 202235 51711
77 - 10.58 | 5.49 Marinus Pharmaceuticals MRNS 6.43 -8.3 5.90 - 7.24 754 581
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/14 72 + 1.10 | 0.40 Mast Therapeutics, Inc. MSTX 0.45 +2.3 0.44 - 0.49 31566 6002
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 11/12 74 - 9.00 | 4.25 Medgenics, Inc. MDGN 5.02 -0.2 5.00 - 5.30 2645 729
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/10 145 - 5.25 | 1.66 Medicinova MNOV 3.07 -4.1 2.95 - 3.20 2224 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 911
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 20/21 121 - 113.61 | 54.37 Medivation MDVN 106.90 -5.2 105.00 - 113.48 54831 51448
77 + 19.31 | 4.60 MediWound Ltd. MDWD 5.84 +16.8 4.80 - 6.09 2032 853
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 12/42 115 - 9.59 | 2.50 Merrimack Pharmaceuticals MACK 8.48 -2.5 8.10 - 8.89 131067 69409
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/2 73 - 2.59 | 1.01 Merus Labs International MSLI 1.44 -3.4 1.44 - 1.54 866 110
56 + 7.90 | 4.08 Minerva Neurosciences NERV 4.29 +2.6 4.08 - 4.70 1147 726
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 10/11 79 - 25.97 | 15.59 Mirati Therapeutics Inc MRTX 16.00 -2.3 15.99 - 16.96 1394 1230
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/20 97 + 22.44 | 7.80 NanoString Technologies NSTG 12.19 +2.5 11.52 - 12.99 4611 3389
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/56 88 - 2.25 | 0.97 Navidea Biopharmaceuticals NAVB 1.16 -4.9 0.97 - 1.21 103602 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 17634
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/15 97 + 15.34 | 10.10 Nektar Therapeutics NKTR 13.63 +2.1 13.36 - 14.25 52401 35336
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/32 99 + 8.29 | 4.56 Neostem NBS 6.17 +27.2 4.86 - 6.46 24074 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 9699
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/50 87 + 3.61 | 1.11 Neptune Tech & Bioresources NEPT 1.92 +13.6 1.72 - 2.00 3785 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1289
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/9 77 + 4.81 | 2.12 Neuralstem CUR 2.86 +7.1 2.68 - 3.14 28076 10145
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 103 - 53.48 | 17.32 NewLink Genetics Corp. NLNK 30.54 -5.0 29.07 - 34.55 43981 27592
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/7 84 + 10.64 | 3.20 Northwest Biotherapeutics Inc NWBO 5.79 +6.8 5.25 - 6.15 23506 10482
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/47 66 - 1.60 | 0.69 NovaBay Pharmaceuticals NBY 0.71 -4.1 0.70 - 0.75 5453 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 809
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 109 + 6.95 | 2.99 Novavax Inc. NVAX 5.28 +6.7 4.94 - 5.38 117918 40724
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/11 103 + 39.68 | 21.77 NPS Pharmaceuticals NPSP 29.00 +5.5 26.00 - 29.96 78975 57584
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/26 93 - 19.94 | 4.47 Ocera Therapeutics OCRX 5.43 -3.2 5.27 - 5.78 912 569
115 + 17.00 | 11.90 Ocular Therapeutix, Inc. OCUL 16.88 +8.7 15.01 - 17.00 4491 3520
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 14/22 84 + 20.00 | 6.01 Ohr Pharmaceutical OHRP 7.23 +2.3 6.83 - 7.50 5453 2460
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/63 140 + 20.39 | 6.92 Omeros OMER 18.98 +9.3 17.00 - 20.39 34803 23492
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 25/26 63 - 14.25 | 2.08 OncoGenex Pharmaceuticals OGXI 2.18 nc 2.08 - 2.20 4800 1938
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/77 55 + 2.70 | 0.40 Oncolytics Biotech (D) ONCY 0.74 +5.7 0.70 - 0.86 38363 5186
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/22 108 - 42.34 | 12.45 OncoMed Pharmaceuticals OMED 20.17 -0.1 19.83 - 22.12 7019 5898
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 10/30 81 - 17.19 | 3.80 Onconova Therapeutics ONTX 4.69 -1.9 4.63 - 4.96 1625 1044
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/9 59 + 4.08 | 1.52 Oncothyreon Inc. ONTY 1.70 +6.3 1.57 - 1.75 13193 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 5193
Bearish Crossover (aka 'Newly Bearish' Trend). The stock's Trend Category has changed from BULLISH to BEARISH. The 13-week MA, which was above the 40-week MA a week previous, has now moved below it. A stock exhibiting this Trends Symbol is in the 1st week of its new BEARISH Trend Category. Trading implications: generally considered a trade exit signal. 1/1 96 - 124.70 | 124.70 Onyx Pharmaceuticals ONXX 124.70 nc nt nt nt
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 19/32 56 + 2.56 | 0.73 Opexa Therapeutics OPXA 0.87 +3.6 0.80 - 0.93 1671 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 324
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/21 98 - 47.99 | 22.61 Ophthotech Corporation OPHT 40.05 -2.9 39.80 - 44.16 17975 15880
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 22/30 49 + 4.65 | 0.79 Oragenics Inc. OGEN 0.88 +2.3 0.80 - 0.95 2489 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 386
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 11/25 70 - 31.73 | 6.33 Oramed Pharmaceuticals ORMP 6.80 -4.2 6.75 - 7.30 1421 846
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 12/13 86 - 18.41 | 11.80 Osiris Therapeutics OSIR 13.05 -3.3 12.92 - 13.74 6216 5431
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 12/13 192 + 24.93 | 5.51 Ovascience Inc. OVAS 24.12 +11.0 20.65 - 24.93 16707 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 8680
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/19 86 - 5.40 | 1.70 Oxigene, Inc. OXGN 1.98 -8.3 1.70 - 2.11 80240 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 13889
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 126 + 8.20 | 3.47 Pacific Biosc. of California PACB 6.80 +4.3 6.42 - 7.00 37231 20407
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/14 41 + 6.22 | 1.61 Pain Therapeutics Inc PTIE 1.72 +0.6 1.62 - 1.77 18878 7637
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/33 169 + 23.76 | 8.99 Paratek Pharmaceuticals, Inc. PRTK 19.48 +2.5 17.66 - 19.70 1512 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 869
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/4 79 - 10.26 | 7.22 PDL BioPharma PDLI 7.79 -2.4 7.70 - 8.29 148958 75239
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/13 83 - 3.18 | 1.24 Peregrine Pharmaceuticals PPHM 1.42 -8.4 1.41 - 1.57 33151 6230
122 - 8.53 | 5.28 Pfenex Inc. PFNX 8.25 -1.1 8.25 - 8.53 892 370
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/9 105 + 154.89 | 82.51 Pharmacyclics PCYC 134.43 +0.7 132.20 - 142.00 32591 29147
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/8 72 - 2.59 | 1.19 PharmAthene PIP 1.63 -5.2 1.63 - 1.74 6022 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1087
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/24 101 + 4.63 | 2.53 Pluristem Therapeutics PSTI 2.80 +5.3 2.53 - 2.81 7393 2426
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/14 97 - 31.48 | 19.59 Portola Pharmaceuticals PTLA 26.57 -3.0 26.30 - 27.98 12307 11516
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 10/27 80 - 13.29 | 1.47 Prana Biotechnology Ltd PRAN 1.73 -0.6 1.64 - 1.84 13250 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 2468
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/14 85 - 1.95 | 0.86 Prima BioMed PBMD 0.98 -1.0 0.86 - 1.04 400 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 61
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/12 122 + 7.45 | 3.10 Progenics Pharmaceutical PGNX 6.33 +17.9 5.37 - 6.86 93565 40967
0 + 21.87 | 11.00 ProQR Therapeutics N.V. PRQR 12.86 +12.4 11.04 - 12.97 2735 2097
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/24 109 - 13.75 | 3.55 Prosensa Holding N.V. RNA 11.27 -7.2 10.98 - 12.48 11513 7152
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 26/27 74 + 5.30 | 1.86 Protalix BioTherapeutics PLX 2.09 +2.5 1.86 - 2.19 34960 4088
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/22 99 - 49.24 | 16.71 Prothena Corporation plc PRTA 21.53 -4.6 20.59 - 24.24 11990 9082
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 17/18 112 - 47.20 | 13.15 PTC Therapeutics PTCT 38.89 -3.4 38.68 - 42.10 14451 13922
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 2/15 82 - 279.37 | 41.00 Puma Biotechnology PBYI 216.22 -8.7 215.00 - 244.93 19376 20312
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 9/18 74 - 7.10 | 3.79 QLT Inc. QLTI 3.96 -0.5 3.90 - 4.00 3086 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1612
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 14/15 217 - 112.70 | 21.75 Receptos, Inc. RCPT 106.55 -2.5 106.40 - 112.38 27437 21705
47 - 9.88 | 2.65 Recro Pharma REPH 2.78 -1.4 2.75 - 3.02 833 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 272
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 19/20 32 - 14.10 | 0.83 Regado BioSciences RGDO 0.86 -7.5 0.84 - 0.90 10009 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1785
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 18/19 109 + 410.18 | 257.69 Regeneron Pharmaceuticals REGN 395.20 +4.6 376.54 - 402.87 38153 53175
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/3 235 - 25.60 | 5.40 Regulus Therapeutics Inc RGLS 17.20 -22.1 17.10 - 25.60 107860 54884
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 33/34 88 - 3.50 | 1.14 Reliv' International RELV 1.16 -3.3 1.16 - 1.24 757 265
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 9/14 70 - 52.74 | 11.90 Relypsa, Inc. RLYP 19.67 -2.9 18.78 - 20.45 13957 7681
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/116 116 + 26.75 | 11.70 Repligen Corp. RGEN 23.30 +1.4 22.33 - 24.19 11357 10883
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 10/47 61 - 22.57 | 5.92 Repros Therapeutics RPRX 9.34 -7.7 8.55 - 10.72 66463 34576
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/2 59 - 39.86 | 14.02 Revance Therapeutics RVNC 15.51 -21.6 14.02 - 21.14 30606 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 14088
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/17 94 - 1.85 | 0.37 Rexahn Pharmaceuticals RNN 0.68 -5.6 0.68 - 0.74 34653 3969
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 21/47 49 - 1.51 | 0.17 Rock Creek Pharmaceuticals RCPI 0.18 -10.0 0.17 - 0.21 40113 3575
78 + 8.47 | 4.02 Ruthigen, Inc. RTGN 4.39 +2.3 4.20 - 5.36 2475 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 989
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/1 68 - 6.84 | 0.32 RXI Pharmaceuticals RXII 1.86 -2.1 1.80 - 1.97 5845 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1271
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 19/22 77 - 24.69 | 9.39 Sangamo BioSciences SGMO 11.21 -1.0 11.12 - 12.29 29371 19751
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/12 65 - 40.00 | 14.31 Sarepta Therapeutics, Inc. SRPT 15.33 -4.9 14.83 - 16.88 68224 41235
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/26 80 - 55.99 | 30.80 Seattle Genetics Inc SGEN 35.36 -1.9 34.76 - 38.70 50255 37801
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 10/27 72 - 4.17 | 1.95 Sequenom Inc. SQNM 2.91 nc 2.86 - 3.05 57269 20201
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 5/95 80 + 264.98 | 129.58 Shire plc SHPG 202.62 +2.0 199.81 - 203.00 50845 43855
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/47 116 + 3.87 | 0.99 SIGA Technologies (Q) SIGA 1.60 +2.6 1.47 - 1.79 6615 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 2230
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/22 90 - 8.14 | 4.51 Sinovac Biotech SVA 5.25 -0.8 5.05 - 5.35 4296 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 2282
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 17/17 71 - 16.40 | 3.10 Sorrento Therapeutics SRNE 4.23 -9.0 4.10 - 4.88 2568 1289
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 3/4 86 - 10.32 | 6.36 Spectrum Pharmaceuticals Inc SPPI 7.21 -1.6 7.13 - 7.60 29243 18407
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 5/6 76 + 2.43 | 1.02 StemCells, Inc. STEM 1.23 +6.0 1.10 - 1.28 54325 9648
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/46 119 - 31.48 | 10.50 Stemline Therapeutics STML 14.12 -3.4 13.67 - 15.40 7361 5588
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/3 22 + 8.46 | 1.00 Sunesis Pharmaceuticals SNSS 1.67 +2.5 1.52 - 1.72 32948 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 10830
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/14 101 + 119.42 | 52.87 Synageva BioPharma GEVA 75.26 +3.3 71.94 - 78.52 10351 9673
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/33 75 + 7.22 | 2.62 Synta Pharmaceuticals SNTA 3.18 +1.3 3.03 - 3.44 51347 19865
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 9/21 79 + 3.64 | 0.95 Synthetic Biologics Inc. SYN 1.50 +0.7 1.36 - 1.51 16972 3545
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/46 83 - 6.11 | 2.25 Targacept TRGT 2.43 -2.4 2.40 - 2.51 4822 2151
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/22 82 - 8.58 | 3.34 Tenax Therapeutics, Inc. TENX 3.70 -5.1 3.66 - 3.90 3687 861
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/7 94 + 40.99 | 22.15 TESARO, Inc. TSRO 29.62 +11.9 26.27 - 30.42 21344 14866
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 10/10 89 + 14.75 | 3.51 TetraLogic Pharmaceuticals TLOG 4.14 +4.8 3.72 - 4.34 3470 1555
170 + 14.65 | 7.20 TG Therapeutics TGTX 14.03 +24.5 11.26 - 14.65 31828 18307
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 17/46 56 - 32.88 | 12.78 Theravance THRX 13.23 -7.3 12.78 - 14.49 71126 37740
61 + 35.68 | 14.75 Theravance Biopharma TBPH 17.48 +2.4 16.81 - 18.74 8681 5151
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/31 66 + 5.93 | 2.58 Threshold Pharmaceuticals THLD 2.87 +5.1 2.73 - 3.44 54913 19279
0 - 30.00 | 9.67 Tokai Pharmaceuticals, Inc. TKAI 15.36 -5.1 15.16 - 16.84 6547 4559
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 6/13 89 - 8.22 | 4.36 Transition Therapeutics Inc TTHI 6.40 -0.5 6.36 - 6.43 504 126
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/3 82 - 9.95 | 4.01 Trevena, Inc. TRVN 5.56 -5.9 5.42 - 5.88 977 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 585
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/2 109 - 7.10 | 2.97 Trovagene, Inc. TROV 4.10 -11.8 4.08 - 4.99 7215 5597
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 3/3 74 - 69.77 | 32.02 Ultragenyx Pharmaceutical RARE 41.91 -6.3 40.58 - 46.45 12720 11533
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/8 83 - 19.25 | 8.34 Vanda Pharmaceuticals VNDA 11.81 +0.2 11.58 - 13.15 24491 16769
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 15/16 72 + 7.45 | 1.90 VBI Vaccines Inc. VBIV 2.39 +0.8 2.38 - 2.54 144 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 80
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 11/12 51 - 19.00 | 6.01 Veracyte, Inc. VCYT 6.77 -12.4 6.01 - 8.10 4328 2474
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/31 97 - 16.60 | 7.10 Verastem, Inc. VSTM 9.06 +0.3 8.87 - 9.52 9353 7046
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 18/19 117 - 117.97 | 59.79 Vertex Pharmaceuticals VRTX 111.34 -4.0 110.05 - 117.97 51953 47538
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/25 83 - 1.79 | 1.01 Vical Inc. VICL 1.12 -1.8 1.12 - 1.16 11586 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 2765
0 + 18.79 | 5.41 Vitae Pharmaceuticals, Inc. VTAE 16.36 +13.3 14.44 - 18.79 16852 8462
72 + 35.20 | 10.66 Vital Therapies VTL 18.76 +9.5 16.81 - 18.99 3424 2516
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 21/61 75 - 10.29 | 3.13 Vivus Inc. VVUS 3.25 -2.4 3.20 - 3.41 109896 44408
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 109 + 14.41 | 5.75 Xencor, Inc. XNCR 11.19 +4.4 10.89 - 11.42 2520 1520
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/5 154 + 8.45 | 3.15 XenoPort XNPT 7.75 +6.3 7.26 - 8.45 41755 23091
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/27 87 + 9.57 | 3.42 Xoma Corp. XOMA 3.92 +2.9 3.66 - 4.15 51164 21855
105 + 21.96 | 16.01 Zafgen, Inc. ZFGN 19.39 +1.1 18.80 - 20.17 1191 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1126
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/26 108 + 5.58 | 2.31 ZIOPHARM Oncology ZIOP 3.73 +18.8 3.13 - 3.88 49453 17924
Highlighted stocks traded at their 52 week high or low, OR gained/lost more than 10% during the trading week.
Business Description :
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. The company integrates the disciplines of biology, crystallography, medicinal chemistry, and computer modeling to discover and develop drugs through the structure-guided drug design process. Its product candidates include peramivir, an intravenous neuraminidase inhibitor, which is approved for seasonal influenza in Japan and Korea, as well as to treat acute influenza; ulodesine, an oral purine nucleoside phosphorylase inhibitor, which has completed Phase II clinical trials for the treatment of gout; and forodesine, an oral purine nucleoside phosphorylase inhibitor that is in Phase II clinical trials for oncology. The companys product candidates also comprise BCX4161, a Phase II oral serine protease inhibitor for hereditary angioedema (HAE); and BCX4430, a preclinical, RNA dependent-RNA polymerase inhibitor for treating Filoviruses, including hemorrhagic fever viruses. Its pre-clinical products also include Two 2nd generation HAE compounds for the prevention of HAE attacks. It has collaborative relationships with Mundipharma International Holdings Limited for the development and commercialization of forodesine; and Shionogi & Co., Ltd. and Green Cross Corporation for the development and commercialization of peramivir. Biocryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Company Website :
  Privacy Policy  |   Terms of Use  |   Syndications  |   Contact Us